These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 22513344

  • 1. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
    Ritt LE, Carvalho AC, Feitosa GS, Pinho-Filho JA, Macedo CR, Vilas-Boas F, Andrade MV, Feitosa-Filho GS, Almeida AJ, Barojas M, Lopes RD.
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):538-43. PubMed ID: 22513344
    [Abstract] [Full Text] [Related]

  • 2. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A, Aronow WS, Vadnerkar A, Sivan K, Mittal S.
    Am J Ther; 2009 Jun; 16(1):5-7. PubMed ID: 19142162
    [Abstract] [Full Text] [Related]

  • 3. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice.
    Passantino A, Lagioia R, Mastropasqua F, Scrutinio D.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):99-105. PubMed ID: 16814655
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY, Metra M, Thabut G, Logeart D, Cohen-Solal A.
    Am J Cardiol; 2006 Aug 15; 98(4):500-3. PubMed ID: 16893705
    [Abstract] [Full Text] [Related]

  • 5. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
    Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ.
    Int J Cardiol; 2005 Jul 10; 102(2):239-47. PubMed ID: 15982491
    [Abstract] [Full Text] [Related]

  • 6. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.
    J Am Soc Echocardiogr; 2004 Mar 10; 17(3):253-61. PubMed ID: 14981424
    [Abstract] [Full Text] [Related]

  • 7. Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial.
    Issa VS, Amaral AF, Cruz FD, Ferreira SM, Guimarães GV, Chizzola PR, Souza GE, Bacal F, Bocchi EA.
    Circ Heart Fail; 2010 Jan 10; 3(1):82-8. PubMed ID: 19933408
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A, Soares R, Feliciano J, Andreozzi V, Silva S, Abreu A, Ramos R, Santos N, Ferreira L, Ferreira RC.
    Rev Port Cardiol; 2011 Oct 10; 30(10):781-7. PubMed ID: 22118129
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
    Guazzi M, Melzi G, Marenzi GC, Agostoni P.
    Clin Pharmacol Ther; 1999 Mar 10; 65(3):319-27. PubMed ID: 10096264
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB, Theodoropoulos TA, Cardinalli-Neto A, Cury PM.
    Am Heart J; 2008 Sep 10; 156(3):422-30. PubMed ID: 18760121
    [Abstract] [Full Text] [Related]

  • 13. Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy.
    Dourado KC, Bestetti RB, Cordeiro JA, Theodoropoulos TA.
    Int J Cardiol; 2006 Apr 14; 108(3):412-3. PubMed ID: 16520133
    [Abstract] [Full Text] [Related]

  • 14. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M.
    Eur Heart J; 2002 May 14; 23(10):806-14. PubMed ID: 12009721
    [Abstract] [Full Text] [Related]

  • 15. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M, Gasparini M, Faletra F, Klersy C, Morenghi E, Galimberti P, Genovese L, Regoli F, De Chiara F, Bragato R, Andreuzzi B, Pini D, Gronda E.
    Am Heart J; 2006 Feb 14; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments.
    Corrà U, Giordano A, Mezzani A, Gnemmi M, Pistono M, Caruso R, Giannuzzi P.
    Eur J Prev Cardiol; 2012 Feb 14; 19(1):32-40. PubMed ID: 21450614
    [Abstract] [Full Text] [Related]

  • 18. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
    Theodoropoulos TA, Bestetti RB, Otaviano AP, Cordeiro JA, Rodrigues VC, Silva AC.
    Int J Cardiol; 2008 Aug 01; 128(1):22-9. PubMed ID: 18258318
    [Abstract] [Full Text] [Related]

  • 19. Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.
    Bestetti RB, Otaviano AP, Cardinalli-Neto A, da Rocha BF, Theodoropoulos TA, Cordeiro JA.
    Int J Cardiol; 2011 Sep 01; 151(2):205-8. PubMed ID: 20591516
    [Abstract] [Full Text] [Related]

  • 20. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R, Cinca J, Bayes-Genis A, Pascual D, Fernandez-Palomeque C, Bardaji A, Almendral J, Nieto V, Macaya C, Jimenez RP, de Luna AB, Muerte Subita En La Insuficiencia Cardiaca (MUSIC) Group.
    J Card Fail; 2008 Sep 01; 14(7):561-8. PubMed ID: 18722321
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.